AzTrials
AzTrials

HypertensionNCT02762695

Effectiveness of a Case Management Model for Patients With Hypertension and Type II Diabetes in Chile

A study testing Case Management in people with Hypertension and Diabetes Mellitus, Type 2, run by Pontificia Universidad Catolica de Chile at 1 site in Chile.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this study is to evaluate whether a new model of health care for chronic patients, based on Case Management and guided by a nurse which targets the patient´s risk, is more effective than usual care at Primary Health care in Chile. Read more about this study

Who is it for?
Ages 18 to 82 years
Conditions the study is for
Hypertension, Diabetes Mellitus, Type 2
What is being tested?
Case Management
Could I receive a placebo?
No, everyone receives an active treatment
How many people
616 participants
Where
1 siteChile
Study dates
4 May 2016to Jun 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 82 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adults diagnosed with Hypertension and/ or Type 2 Diabetes

Who cannot join

  • Severe mental illness and / or deterioration of cognitive abilities.
  • Severe hearing loss.
  • Diagnosed with cancer
  • Stage 4 or 5 of chronic kidney disease

Trial locations and contacts

1 site in 1 country.

Chile1 site
  • CESFAM La Faena

    Peñalolén, RM

Other trials in Chile

About this study

Official title: Evaluation of a Model of Care for People With Hypertension and Type II Diabetes Based on Case Management and Risk Adjustment

The purpose of this study is to evaluate whether a new model of health care for chronic patients, based on Case Management and guided by a nurse which targets the patient´s risk, is more effective than usual care at Primary Health care in Chile. Additionally, this intervention would provide a better quality of care and a more efficient health provision.

Being tested
Case Management, Usual Care
Keywords
Hypertension, Diabetes Mellitus, Type 2, Case Management
Medical subject headings
Hypertension, Diabetes Mellitus, Type 2

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Case ManagementOther

    A model of health care for chronic patients, based on Case Management and guided by a nurse which targets the patient´s risk.

    The core elements of this strategy are: a. processes to identify specific population and their risk; b. evidence-based practice guidelines according to risk (higher risk, more interventions and monitoring by a nurse, lower risk, higher emphasis on self-care); c. Practice models based on collaboration between health team members leaded by a nurse; d. self-management education for patients; e. monitoring patients face to face or by telephone to ensure to follow the care program (blood test, medical consultation, for example); e. measurement of process and outcomes.

  • Usual CareOther

    Usual Care at Primary Health Care Center

Study groups in NCT02762695
Study groupRoleWhat they receive
Case ManagementExperimentalNot described
Receives: Other: Case Management
ControlActive comparatorUsual Care at Primary Health Care
Receives: Other: Usual Care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Glycated Hemoglobin

    Measured: One year

  2. Systolic and Diastolic Blood Pressure

    Measured: One year

Secondary outcomes (3)
  1. Quality of Care

    Measured by Clinical records audits

    Measured: one year

  2. Patient satisfaction

    Measured by a questionnaire

    Measured: one year

  3. Medication adherence

    Measured by Morisky- Green questionnaire

    Measured: one year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 May 2016 (estimated)
  2. Study start4 May 2016
  3. Primary completionJun 2018 (estimated)
  4. Study completionJun 2018 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
616 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02762695
Sponsor's protocol ID
15-277
Other IDs
ID15I10277
Status last verified
Sep 2017
First submitted
3 May 2016
Last updated
28 Sep 2017
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Case Management in people with Hypertension and Diabetes Mellitus, Type 2, run by Pontificia Universidad Catolica de Chile at 1 site in Chile.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 28 Sep 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Chile. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Glycated Hemoglobin (time frame: One year). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Sep 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in